Chargement en cours...

Cardiovascular disease risk factors among transgender women in Chiang Mai, Thailand

Transgender individuals take hormone therapy (HT) for transitioning secondary sexual characteristics, especially by transgender women assigned male at birth (AMAB). The transgender drug is a relatively new field in health care, but limited data exist to inform the cardiovascular risk factor profile...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Cardiovasc Dis
Auteurs principaux: Kulprachakarn, Kanokwan, Ounjaijean, Sakaewan, Rerkasem, Kittipan, Molinsky, Rebecca L, Demmer, Ryan T
Format: Artigo
Langue:Inglês
Publié: e-Century Publishing Corporation 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364281/
https://ncbi.nlm.nih.gov/pubmed/32685270
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!